Skip to content
1887

Abstract

Artificial intelligence (AI) and machine learning (ML) are reshaping microbiology, enabling rapid antibiotic discovery, resistance prediction and clinical diagnostics. For microbiologists, the goal is not to build new algorithms but to recognize when ML is appropriate, how to prepare data and how to interpret outputs responsibly. This primer takes that practical stance – driving the ML car rather than rebuilding the engine. At a high level, ML learns from complex patterns, often noisy data. In antibiotic discovery, ML models help identify compounds in biological data and design new ones from scratch using generative AI. In microbiome studies, where measurements are compositional, sparse and often confounded, ML helps uncover community structure and link taxa or functions to phenotypes. In pathogen genomics, supervised models map sequence-derived features (e.g. k‑mers, SNPs and gene presence/absence) to outcomes such as species identity, antimicrobial susceptibility or MIC. Unsupervised learning supports exploration, including clustering, latent gradients and dimensionality reduction for visualization. Across these settings, success hinges less on exotic architectures than on sound problem framing, careful preprocessing and experimental validation.

  • This is an open-access article distributed under the terms of the Creative Commons Attribution License. This article was made open access via a Publish and Read agreement between the Microbiology Society and the corresponding author’s institution.
Loading

Article metrics loading...

/content/journal/micro/10.1099/mic.0.001629
2025-11-13
2025-12-17

Metrics

Loading full text...

Full text loading...

/deliver/fulltext/micro/171/11/mic001629.html?itemId=/content/journal/micro/10.1099/mic.0.001629&mimeType=html&fmt=ahah

References

  1. Wong F, de la Fuente-Nunez C, Collins JJ. Leveraging artificial intelligence in the fight against infectious diseases. Science 2023; 381:164–170 [View Article] [PubMed]
    [Google Scholar]
  2. de la Fuente-Nunez C, Collins JJ. Essay: using machine learning for antibiotic discovery. Phys Rev Lett 2025; 135:030001 [View Article] [PubMed]
    [Google Scholar]
  3. Porto WF, Irazazabal L, Alves ESF, Ribeiro SM, Matos CO et al. In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design. Nat Commun 2018; 9:1490 [View Article] [PubMed]
    [Google Scholar]
  4. Krishnan A, Anahtar MN, Valeri JA, Jin W, Donghia NM et al. A generative deep learning approach to de novo antibiotic design. Cell 2025; 188:5962–5979 [View Article] [PubMed]
    [Google Scholar]
  5. Wong F, Zheng EJ, Valeri JA, Donghia NM, Anahtar MN et al. Discovery of a structural class of antibiotics with explainable deep learning. Nature 2024; 626:177–185 [View Article] [PubMed]
    [Google Scholar]
  6. Santos-Júnior CD, Torres MDT, Duan Y, Rodríguez Del Río Á, Schmidt TSB et al. Discovery of antimicrobial peptides in the global microbiome with machine learning. Cell 2024; 187:3761–3778 [View Article] [PubMed]
    [Google Scholar]
  7. Torres MDT, Brooks EF, Cesaro A, Sberro H, Gill MO et al. Mining human microbiomes reveals an untapped source of peptide antibiotics. Cell 2024; 187:5453–5467 [View Article] [PubMed]
    [Google Scholar]
  8. Wan F, Torres MDT, Peng J, de la Fuente-Nunez C. Deep-learning-enabled antibiotic discovery through molecular de-extinction. Nat Biomed Eng 2024; 8:854–871 [View Article] [PubMed]
    [Google Scholar]
  9. López-Cortés XA, Manríquez-Troncoso JM, Hernández-García R, Peralta D. MSDeepAMR: antimicrobial resistance prediction based on deep neural networks and transfer learning. Front Microbiol 2024; 15:1361795 [View Article] [PubMed]
    [Google Scholar]
  10. de la Fuente-Nunez C. AI in infectious diseases: the role of datasets. Drug Resist 2024; 73:101067 [View Article]
    [Google Scholar]
/content/journal/micro/10.1099/mic.0.001629
Loading
/content/journal/micro/10.1099/mic.0.001629
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An error occurred
Approval was partially successful, following selected items could not be processed due to error